Identified issues, page-24

1. How long have u been a shareholder for

2. Timelines cant always be absolutely defined ...particularly in biological trials and more so when the operation of same is out of your control .

3. Your summary effectively means that the ceo should make absolutel no comment...until they actually have the results...

Or alternately ...

4 . Preface any comment with

> Hopefully we shall receive...
> Subject to
> we are expecting sometime

5. Whats your definition of soon


The unanimous view l would suggest is that getting someone like BMQ with such a multi diverse skill set was a great bonus to holders of CHM shares .

She appears to be well connected and has the ability to foster new connections .

Connections that count .

She also has excellent communication skills and the
ability to dissect and explain some of the highly techical concepts involved in the R&D concerned .

My view is that these skills are going to be critical when it comes to leveraging off results and data should the opportunity arrise .

We are talking communication with contempories in the field which may/could result in potential value creation to the CHM shareholders orders of magitude than current levels

By all means go on your crusade, which l suggest is more about blowing yr own trumpet than anything else.

Have a pleasant evening